Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

MediWound Ltd. (MDWD) vs NovaBridge Biosciences (NBP)

MediWound Ltd. and NovaBridge Biosciences are both Biotechnology companies. MediWound Ltd. and NovaBridge Biosciences are of similar size ($178.6M and $172.8M). MediWound Ltd. grew revenue faster over the last twelve months: −40.3% against −91.8%. NovaBridge Biosciences has the higher net margin (0.00% vs −170.1%) and the higher return on invested capital (0.00% vs −6,551.8%). Across the 17 metrics below, NovaBridge Biosciences leads on 12 and MediWound Ltd. on 5.

Valuation

Metric MDWD NBP Biotechnology median
P/E n/m n/m 7.88
P/S 15.04 5.81 11.47
P/B 5.01 0.56 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m 1.86 0.74
EV/Sales 12.14 (3.66) 10.73
Earnings yield (11.55%) (35.25%) (28.84%)
Free cash flow yield (16.01%) (82.02%) (23.03%)

Profitability

Metric MDWD NBP Biotechnology median
Gross margin 15.46% 31.10% 65.16%
Operating margin (267.75%) 0.00% 0.00%
Net margin (170.10%) 0.00% 0.00%
Free cash flow margin (240.47%) 0.00% 0.00%
Return on equity (75.42%) 0.00% (57.72%)
Return on assets (29.06%) 0.00% (49.22%)
Return on invested capital (6,551.77%) 0.00% 0.00%

Growth

Metric MDWD NBP Biotechnology median
Revenue growth (TTM) (40.26%) (91.84%) 5.64%
EPS growth (last fiscal year) 30.69% (77.78%) —
Revenue growth, 5-year CAGR (4.87%) (40.00%) 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric MDWD NBP Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.32 7.64 4.73
Net debt to EBITDA 2.27 2.26 0.96

Dividend

Metric MDWD NBP Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric MDWD NBP Biotechnology median
Market cap 178.55m 172.84m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack